Name | Title | Contact Details |
---|
TOMLYN PRODUCTS is a Fort Worth, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
YO1 Center is a destination well-being place which enhances health, agility and longevity and brings your state of mind to bliss and happiness. Built at the erstwhile Kutsher`s Resort in lush green surroundings that have two large lakes, it gives guests the opportunity to naturally revitalize their mind and body by employing the Eastern practices brought all the way from India, namely Naturopathy (or Nature Cure), Ayurveda, Yoga and Meditation, Physical Therapy, Acupuncture, Diet and Nutrition. YO1 (or Yauvan) in Sanskrit means Youth. It is the golden period in every human being`s life between teenage and adulthood. It highlights the yogic behavior of every individual in all walks of life. YO1 represents the manifestation of Yoga to fulfill the human quest of attaining eternal youth, through a complete rejuvenation of mind, body and soul. YO1 is about You+1, the literal Sanskrit meaning of Yoga being the `divine union`.
Eureka93 is one of the largest hemp cultivation and CBD extraction operations in North America. We are dedicated to producing the highest quality CBD products for our customers.
About LMC: Since 1969, Laboratory Medicine Consultants (LMC) has served the diagnostic pathology needs of Las Vegas. All of the pathologists at LMC are board certified, and many of the pathologists are subspecialty board certified or have doctorate
Kolltan Pharmaceuticals is a private company founded in 2007 that is developing novel monoclonal antibody (mAb) drugs targeting receptor tyrosine kinases (RTKs). Kolltan's primary targets derive from seminal discoveries made in the laboratory of Dr. Joseph Schlessinger, Chairman of the Department of Pharmacology at the Yale School of Medicine, and in Kolltan’s laboratories. Dr. Schlessinger's laboratory has characterized a novel molecular mechanism underlying activation of RTKs providing, for the first time, a clear molecular explanation — at atomic resolution — for the oncogenic activity of mutations that have been identified in a variety of human cancers.